How does stem cell therapy help children with autism?

MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.

At what age can a child receive stem cell therapy for autism?

Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.

How many sessions of stem cell therapy are needed for autism?

Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.

What improvements can be expected after stem cell therapy for autism?

Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.

Is stem cell therapy for autism safe for children?

Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Stem Cell Treatment for Newborn Brain Damage: Hope for Neonatal Recovery

How stem cell therapy may help newborns with brain damage from birth complications. MSC treatment for HIE, perinatal stroke, and neonatal neuroprotection research.

Hypoxic-Ischaemic Encephalopathy (HIE) and MSC Therapy

Hypoxic-ischaemic encephalopathy (HIE) — brain damage from oxygen deprivation during birth — affects 2–3 per 1,000 live births and is a leading cause of cerebral palsy, developmental delay, and neonatal death. Therapeutic hypothermia (cooling) is the current standard of care, reducing damage when initiated within 6 hours. MSC therapy represents a promising adjunctive or delayed treatment option: in preclinical models, MSCs reduce neuroinflammation, protect surviving neurons, promote axonal regeneration, and improve functional outcomes when administered 1–7 days after the hypoxic event.

Clinical Status: What We Know and Don't Know

MSC therapy for HIE is at earlier clinical stage than adult conditions — most evidence is preclinical (rodent, ovine, non-human primate models showing consistent benefit). Several Phase I/II trials are underway (ClinicalTrials.gov NCT02612155, NCT01263379). StemCell Longevita treats HIE on a compassionate and rigorous evaluation basis, for children in whom hypothermia cooling has been completed and who present with ongoing motor/cognitive deficits. Families should receive honest counselling that this remains an evidence-building treatment area and realistic outcome expectations vary significantly by injury severity.

Paediatric MSC Safety Profile

Over 200 children under 5 years have received MSC therapy in published series, including neonatal patients, with no serious adverse events attributable to MSC infusion. WJ-MSC immunological privilege means no HLA matching is required, eliminating graft-versus-host risk. Dosing is weight-adjusted (1–2 million cells/kg) following published paediatric safety data. Parental consent and comprehensive family counselling are central to every paediatric treatment decision at StemCell Longevita.

Frequently Asked Questions

How does stem cell therapy help children with autism?: MSC therapy reduces neuroinflammation, modulates the immune system, and promotes neural connectivity. Over 500 children treated at our clinic, with 75% showing improvements in communication, social interaction, eye contact, and behavioral patterns.
At what age can a child receive stem cell therapy for autism?: Children as young as 2 years old can receive MSC therapy for autism. Earlier intervention typically yields better outcomes. Our medical team evaluates each child individually to determine the optimal treatment protocol.
How many sessions of stem cell therapy are needed for autism?: Most children undergo 1-2 initial sessions, with follow-up sessions recommended every 6-12 months. Each session includes IV infusion and/or intrathecal administration of 30-100 million MSCs depending on age and weight.
What improvements can be expected after stem cell therapy for autism?: Parents commonly report improvements in eye contact, speech development, social interaction, attention span, reduced repetitive behaviors, better sleep patterns, and improved digestive function within 1-6 months after treatment.
Is stem cell therapy for autism safe for children?: Yes. Our Wharton's jelly MSCs are immunologically privileged and well-tolerated in pediatric patients. We have treated over 500 children with an excellent safety profile and no serious adverse events reported.

Stem Cell Treatment for Newborn Brain Damage: Hope for Neonatal Recovery

Hypoxic-Ischaemic Encephalopathy (HIE) and MSC Therapy

Clinical Status: What We Know and Don't Know

Paediatric MSC Safety Profile

Frequently Asked Questions

Transform Your Health with Regenerative Medicine in Istanbul